Elsevier launches Online Version of the Chinese Journal of Natural Medicines

First time traditional Chinese medicine journal in English is available on ScienceDirect

Beijing, China, 10 June 2009. Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of the online version of the Chinese Journal of Natural Medicines (CJNM). Established in 2003, the Chinese Journal of Natural Medicines is now available for the first time in English on ScienceDirect.

This peer-reviewed journal is for pharmaceutical and medical scientists interested in the advancement of traditional Chinese medicines, and publishes papers on a broad spectrum of bioactive natural products, leading compounds and materials derived from traditional Chinese medicines.

Until now, much of Chinese research was only available in Chinese, but with the Chinese Journal of Natural Medicines now available in English, new findings in the field of traditional Chinese medicine are accessible to a wider and more international audience.

Zheng Xiaonan, the director of the editorial office, said: “The publication of the Chinese Journal of Natural Medicines on ScienceDirect will help us spread the latest scientific achievements and highlight Chinese research articles in this field to the global pharmaceutical community.”
CJNM is one of several journals published by the Chinese Pharmaceutical University, one of the top Chinese universities in this field. The Chinese Pharmaceutical University provides strong academic and financial support to CJNM.

China recognizes the importance of investing in local medical developments and has made efforts to increase the visibility and use of Chinese Traditional Medicines. As part of these efforts, the Chinese central government has invested in Chinese hospitals and the State Council issued a policy to further support and develop the Chinese medical industry. The increased publication of Chinese focused medical research plays an important role in this overall effort.

Hugo Zhang, Managing Director of Elsevier’s Science & Technology division in China, commented: “We expect to see a growing number of quality research articles in this area published in the future. By offering the Chinese Journal of Natural Medicines online and in English, we add unique content to our existing journal collection. Having this journal available in English will be a new and important way to share research developments to the international science community and help them get a better understanding of Chinese medical research and policy. ”

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact:
Shira Tabachnikoff
Elsevier
+31 20 485 2736
s.tabachnikoff@elsevier.com